Biocryst Pharmaceuticals Inc.

+0.38 (+3.26%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.14B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8.02 Million
Adjusted EPS-$0.27
See more estimates
10-Day MA$11.30
50-Day MA$11.18
200-Day MA$6.89
See more pivots

Biocryst Pharmaceuticals Inc. Stock, NASDAQ:BCRX

4505 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8457
United States of America
Phone: +1.919.859.1302
Number of Employees: 246


BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the development and discovery of novel, oral, and small-molecule medicines. It focuses on the oral treatments for rare diseases in which significant unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. The company was founded in 1986 and is headquartered in Durham, NC.